NLP in Healthcare and Life Sciences Market Size, Share, and Trends 2024 to 2034

The global NLP in healthcare and life sciences market size is calculated at USD 7.76 billion in 2025 and is predicted to surpass around USD 58.83 billion by 2034, accelerating at a CAGR of 25.46% from 2025 to 2034. The North America NLP in healthcare and life sciences market size surpassed USD 2.07 billion in 2024 and is expanding at a CAGR of 25.49% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : January 2025
  • Report Code : 3228
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on NLP in Healthcare and Life Sciences Market 

5.1. COVID-19 Landscape: NLP in Healthcare and Life Sciences Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global NLP in Healthcare and Life Sciences Market, By NLP Type

8.1. NLP in Healthcare and Life Sciences Market, by NLP Type

8.1.1. Rule-based

8.1.1.1. Market Revenue and Forecast

8.1.2. Statistical

8.1.2.1. Market Revenue and Forecast

8.1.3. Hybrid

8.1.3.1. Market Revenue and Forecast

Chapter 9. Global NLP in Healthcare and Life Sciences Market, By Component Type

9.1. NLP in Healthcare and Life Sciences Market, by Component Type

9.1.1. Service

9.1.1.1. Market Revenue and Forecast

9.1.2. Solutions

9.1.2.1. Market Revenue and Forecast

Chapter 10. Global NLP in Healthcare and Life Sciences Market, By Deployment Mode 

10.1. NLP in Healthcare and Life Sciences Market, by Deployment Mode

10.1.1. On-Premise

10.1.1.1. Market Revenue and Forecast

10.1.2. Cloud

10.1.2.1. Market Revenue and Forecast

Chapter 11. Global NLP in Healthcare and Life Sciences Market, By Application

11.1. NLP in Healthcare and Life Sciences Market, by Application

11.1.1. Optical Character Recognition (OCR)

11.1.1.1. Market Revenue and Forecast

11.1.2. Auto Coding

11.1.2.1. Market Revenue and Forecast

11.1.3. Interactive Voice Response

11.1.3.1. Market Revenue and Forecast

11.1.4. Pattern And Image Recognition

11.1.4.1. Market Revenue and Forecast

11.1.5. Text Analytics

11.1.5.1. Market Revenue and Forecast

11.1.6. Others

11.1.6.1. Market Revenue and Forecast

Chapter 12. Global NLP in Healthcare and Life Sciences Market, By End-User

12.1. NLP in Healthcare and Life Sciences Market, by End-User

12.1.1. Physician

12.1.1.1. Market Revenue and Forecast

12.1.2. Patients

12.1.2.1. Market Revenue and Forecast

12.1.3. Researchers

12.1.3.1. Market Revenue and Forecast

12.1.4. Clinical Operators

12.1.4.1. Market Revenue and Forecast

Chapter 13. Global NLP in Healthcare and Life Sciences Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by NLP Type

13.1.2. Market Revenue and Forecast, by Component Type

13.1.3. Market Revenue and Forecast, by Deployment Mode

13.1.4. Market Revenue and Forecast, by Application

13.1.5. Market Revenue and Forecast, by End-User

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by NLP Type

13.1.6.2. Market Revenue and Forecast, by Component Type

13.1.6.3. Market Revenue and Forecast, by Deployment Mode

13.1.6.4. Market Revenue and Forecast, by Application

13.1.6.5. Market Revenue and Forecast, by End-User  

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by NLP Type

13.1.7.2. Market Revenue and Forecast, by Component Type

13.1.7.3. Market Revenue and Forecast, by Deployment Mode

13.1.7.4. Market Revenue and Forecast, by Application

13.1.7.5. Market Revenue and Forecast, by End-User

13.2. Europe

13.2.1. Market Revenue and Forecast, by NLP Type

13.2.2. Market Revenue and Forecast, by Component Type

13.2.3. Market Revenue and Forecast, by Deployment Mode

13.2.4. Market Revenue and Forecast, by Application  

13.2.5. Market Revenue and Forecast, by End-User  

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by NLP Type

13.2.6.2. Market Revenue and Forecast, by Component Type

13.2.6.3. Market Revenue and Forecast, by Deployment Mode

13.2.7. Market Revenue and Forecast, by Application  

13.2.8. Market Revenue and Forecast, by End-User  

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by NLP Type

13.2.9.2. Market Revenue and Forecast, by Component Type

13.2.9.3. Market Revenue and Forecast, by Deployment Mode

13.2.10. Market Revenue and Forecast, by Application

13.2.11. Market Revenue and Forecast, by End-User

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by NLP Type

13.2.12.2. Market Revenue and Forecast, by Component Type

13.2.12.3. Market Revenue and Forecast, by Deployment Mode

13.2.12.4. Market Revenue and Forecast, by Application

13.2.13. Market Revenue and Forecast, by End-User

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by NLP Type

13.2.14.2. Market Revenue and Forecast, by Component Type

13.2.14.3. Market Revenue and Forecast, by Deployment Mode

13.2.14.4. Market Revenue and Forecast, by Application

13.2.15. Market Revenue and Forecast, by End-User

13.3. APAC

13.3.1. Market Revenue and Forecast, by NLP Type

13.3.2. Market Revenue and Forecast, by Component Type

13.3.3. Market Revenue and Forecast, by Deployment Mode

13.3.4. Market Revenue and Forecast, by Application

13.3.5. Market Revenue and Forecast, by End-User

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by NLP Type

13.3.6.2. Market Revenue and Forecast, by Component Type

13.3.6.3. Market Revenue and Forecast, by Deployment Mode

13.3.6.4. Market Revenue and Forecast, by Application

13.3.7. Market Revenue and Forecast, by End-User

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by NLP Type

13.3.8.2. Market Revenue and Forecast, by Component Type

13.3.8.3. Market Revenue and Forecast, by Deployment Mode

13.3.8.4. Market Revenue and Forecast, by Application

13.3.9. Market Revenue and Forecast, by End-User

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by NLP Type

13.3.10.2. Market Revenue and Forecast, by Component Type

13.3.10.3. Market Revenue and Forecast, by Deployment Mode

13.3.10.4. Market Revenue and Forecast, by Application

13.3.10.5. Market Revenue and Forecast, by End-User

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by NLP Type

13.3.11.2. Market Revenue and Forecast, by Component Type

13.3.11.3. Market Revenue and Forecast, by Deployment Mode

13.3.11.4. Market Revenue and Forecast, by Application

13.3.11.5. Market Revenue and Forecast, by End-User

13.4. MEA

13.4.1. Market Revenue and Forecast, by NLP Type

13.4.2. Market Revenue and Forecast, by Component Type

13.4.3. Market Revenue and Forecast, by Deployment Mode

13.4.4. Market Revenue and Forecast, by Application

13.4.5. Market Revenue and Forecast, by End-User

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by NLP Type

13.4.6.2. Market Revenue and Forecast, by Component Type

13.4.6.3. Market Revenue and Forecast, by Deployment Mode

13.4.6.4. Market Revenue and Forecast, by Application

13.4.7. Market Revenue and Forecast, by End-User

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by NLP Type

13.4.8.2. Market Revenue and Forecast, by Component Type

13.4.8.3. Market Revenue and Forecast, by Deployment Mode

13.4.8.4. Market Revenue and Forecast, by Application

13.4.9. Market Revenue and Forecast, by End-User

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by NLP Type

13.4.10.2. Market Revenue and Forecast, by Component Type

13.4.10.3. Market Revenue and Forecast, by Deployment Mode

13.4.10.4. Market Revenue and Forecast, by Application

13.4.10.5. Market Revenue and Forecast, by End-User

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by NLP Type

13.4.11.2. Market Revenue and Forecast, by Component Type

13.4.11.3. Market Revenue and Forecast, by Deployment Mode

13.4.11.4. Market Revenue and Forecast, by Application

13.4.11.5. Market Revenue and Forecast, by End-User

13.5. Latin America

13.5.1. Market Revenue and Forecast, by NLP Type

13.5.2. Market Revenue and Forecast, by Component Type

13.5.3. Market Revenue and Forecast, by Deployment Mode

13.5.4. Market Revenue and Forecast, by Application

13.5.5. Market Revenue and Forecast, by End-User

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by NLP Type

13.5.6.2. Market Revenue and Forecast, by Component Type

13.5.6.3. Market Revenue and Forecast, by Deployment Mode

13.5.6.4. Market Revenue and Forecast, by Application

13.5.7. Market Revenue and Forecast, by End-User

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by NLP Type

13.5.8.2. Market Revenue and Forecast, by Component Type

13.5.8.3. Market Revenue and Forecast, by Deployment Mode

13.5.8.4. Market Revenue and Forecast, by Application

13.5.8.5. Market Revenue and Forecast, by End-User

Chapter 14. Company Profiles

14.1. 3M

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Cerner Corporation

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Ardigen

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. IBM Corporation

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. IQVIA Inc

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Apixio Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Edifecs

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Wave Health Technologies

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Inovalon

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Lexlytics

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global NLP in healthcare and life sciences market size is expected to increase USD 58.83 billion by 2034 from USD 6.09 billion in 2024.

The global NLP in healthcare and life sciences market will register growth rate of 25.46% between 2025 and 2034.

The major players operating in the NLP in healthcare and life sciences market are 3M, Cerner Corporation, Ardigen, IBM Corporation, IQVIA Inc, Apixio Inc., Edifecs, Wave Health Technologies, Inovalon, Lexlytics, Conversica Inc., Sparkcognition, Stats LLC, and Others.

The driving factors of the NLP in healthcare and life sciences market are the rising need for accurate processing of large volumes of unstructured data and rising demand for improved clinical documentation.

North America region will lead the global NLP in healthcare and life sciences market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client